These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8847230)

  • 21. HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes.
    Duquesnoy RJ; Mulder A; Askar M; Fernandez-Vina M; Claas FH
    Hum Immunol; 2005 Jul; 66(7):749-61. PubMed ID: 16112022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule.
    van de Wal Y; Kooy YM; Drijfhout JW; Amons R; Papadopoulos GK; Koning F
    Immunogenetics; 1997; 46(6):484-92. PubMed ID: 9321428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alloreactive T-cell clones identify multiple HLA-DQw3 variants.
    Mickelson EM; Masewicz SA; Nepom GT; Martin PJ; Hansen JA
    Hum Immunol; 1991 Jan; 30(1):32-40. PubMed ID: 1705927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of a Selective Islet Peptidome Presented by the Highest-Risk HLA-DQ8trans Molecule.
    van Lummel M; van Veelen PA; de Ru AH; Pool J; Nikolic T; Laban S; Joosten A; Drijfhout JW; Gómez-Touriño I; Arif S; Aanstoot HJ; Peakman M; Roep BO
    Diabetes; 2016 Mar; 65(3):732-41. PubMed ID: 26718497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The P9 pocket of HLA-DQ2 (non-Aspbeta57) has no particular preference for negatively charged anchor residues found in other type 1 diabetes-predisposing non-Aspbeta57 MHC class II molecules.
    Quarsten H; Paulsen G; Johansen BH; Thorpe CJ; Holm A; Buus S; Sollid LM
    Int Immunol; 1998 Aug; 10(8):1229-36. PubMed ID: 9723710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2).
    Godkin A; Friede T; Davenport M; Stevanovic S; Willis A; Jewell D; Hill A; Rammensee HG
    Int Immunol; 1997 Jun; 9(6):905-11. PubMed ID: 9199974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization of serologic recognition sites in the human HLA-A2 molecule.
    Santos-Aguado J; Barbosa JA; Biro PA; Strominger JL
    J Immunol; 1988 Oct; 141(8):2811-8. PubMed ID: 2459229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-DQ molecules as affinity matrix for identification of gluten T cell epitopes.
    Dørum S; Bodd M; Fallang LE; Bergseng E; Christophersen A; Johannesen MK; Qiao SW; Stamnaes J; de Souza GA; Sollid LM
    J Immunol; 2014 Nov; 193(9):4497-506. PubMed ID: 25261484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Large-scale characterization of natural ligands explains the unique gluten-binding properties of HLA-DQ2.
    Stepniak D; Wiesner M; de Ru AH; Moustakas AK; Drijfhout JW; Papadopoulos GK; van Veelen PA; Koning F
    J Immunol; 2008 Mar; 180(5):3268-78. PubMed ID: 18292551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA-DQ polymorphisms are highly selective for peptide binding interactions.
    Kwok WW; Nepom GT; Raymond FC
    J Immunol; 1995 Sep; 155(5):2468-76. PubMed ID: 7650377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A human monoclonal hybridoma antibody (TrJ1) specific for HLA-DQ2.
    Ge J; Bartnes K; Hannestad K
    Tissue Antigens; 1993 Feb; 41(2):81-5. PubMed ID: 8386401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule.
    Kapoerchan VV; Wiesner M; Hillaert U; Drijfhout JW; Overhand M; Alard P; van der Marel GA; Overkleeft HS; Koning F
    Mol Immunol; 2010 Feb; 47(5):1091-7. PubMed ID: 19962195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of peptides to HLA-DQ molecules: peptide binding properties of the disease-associated HLA-DQ(alpha 1*0501, beta 1*0201) molecule.
    Johansen BH; Buus S; Vartdal F; Viken H; Eriksen JA; Thorsby E; Sollid LM
    Int Immunol; 1994 Mar; 6(3):453-61. PubMed ID: 8186196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-A2.1 and HLA-A2.3.
    Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1988 Oct; 141(7):2519-25. PubMed ID: 2459215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-DR beta chain residues that are predicted to be located in the floor of the peptide-binding groove contribute to antibody-binding epitopes.
    Klohe E; Fu XT; Ballas M; Karr RW
    Hum Immunol; 1993 May; 37(1):51-8. PubMed ID: 7690741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T cells recognize a peptide derived from alpha-gliadin presented by the celiac disease-associated HLA-DQ (alpha 1*0501, beta 1*0201) heterodimer.
    Gjertsen HA; Lundin KE; Sollid LM; Eriksen JA; Thorsby E
    Hum Immunol; 1994 Apr; 39(4):243-52. PubMed ID: 7520895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A panel of unique HLA-A2 mutant molecules define epitopes recognized by HLA-A2-specific antibodies and cytotoxic T lymphocytes.
    Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1989 Mar; 142(6):2097-104. PubMed ID: 2466083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA-DR and -DQ epitopes and monoclonal antibody specificity.
    Marsh SG; Bodmer JG
    Immunol Today; 1989 Sep; 10(9):305-12. PubMed ID: 2480137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA binding and T cell recognition of a tissue transglutaminase-modified gliadin epitope.
    Quarsten H; Molberg O; Fugger L; McAdam SN; Sollid LM
    Eur J Immunol; 1999 Aug; 29(8):2506-14. PubMed ID: 10458765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Equilibrium and kinetic analysis of the unusual binding behavior of a highly immunogenic gluten peptide to HLA-DQ2.
    Xia J; Sollid LM; Khosla C
    Biochemistry; 2005 Mar; 44(11):4442-9. PubMed ID: 15766274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.